3 results
Approved WMORecruiting
The objective is to assess the effect of adalimumab on selfconfidence and sexuality of patients with anogenital psoriasis.
Approved WMORecruiting
Objectives1. Determine efficacy of adalimumab as the first biologic agent or after previous use of other anti-TNF blocking agent. Efficacy will be evaluated by means of the ASAS 20% response criteria.2. Determine the efficacy of adalimumab on…
Approved WMORecruiting
To assess non-inferiority of extending the adalimumab dosing interval, under strict disease monitoring in CD patients in sustained (>9months) clinical remission, compared to standard care.